Although there is a significant correlation between the level of apolipoprotein A1 and PAGln, the ratio of apolipoprotein A1 and apolipoprotein B is usually used as a marker in clinical practice for the diagnosis of cardiovascular disease, with a threshold of 1.0. This evidence concerns the gene APOA1 and cardiovascular disorder.